form8k.htm

0001341004-10-002096.txt : 20101220 0001341004-10-002096.hdr.sgml : 20101220 20101220091130 ACCESSION NUMBER: 0001341004-10-002096 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20101220 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20101220 DATE AS OF CHANGE: 20101220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDTRONIC INC CENTRAL INDEX KEY: 0000064670 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 410793183 STATE OF INCORPORATION: MN FISCAL YEAR END: 0429 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07707 FILM NUMBER: 101261656 BUSINESS ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 BUSINESS PHONE: 7635144000 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PKWY CITY: MINNEAPOLIS STATE: MN ZIP: 55432 8-K 1 form8k.htm FORM 8-K form8k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8−K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 20, 2010

Medtronic, Inc.

(Exact name of Registrant as Specified in its Charter)

Minnesota (State or other jurisdiction of incorporation)	1−7707 (Commission File Number)	41−0793183 (IRS Employer Identification No.)

710 Medtronic Parkway Minneapolis, Minnesota (Address of principal executive offices)		55432 (Zip Code)

(763) 514−4000

(Registrant's telephone number, including area code):

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8−K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

£	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
£	Soliciting material pursuant to Rule 14a−12 under the Exchange Act (17 CFR 240.14a−12)
£	Pre-commencement communications pursuant to Rule 14d−2(b) under the Exchange Act (17 CFR 240.14d−2(b))
£	Pre-commencement communications pursuant to Rule 13e−4(c) under the Exchange Act (17 CFR 240.13e−4(c))

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.

On December 20, 2010, Medtronic, Inc. (the "Company") announced that William A. Hawkins intends to retire as Chairman of the Company's Board of Directors, as Chief Executive Officer of the Company, and as a member of the Company's Board of Directors, effective at the conclusion of the Company's fiscal year ending April 29, 2011 or at such time that his successor is appointed. The Company’s Board of Directors has initiated an external search for Mr. Hawkins's successor.

Item 9.01	Financial Statements and Exhibits.

(d)

99.1	Press Release of Medtronic, Inc., dated December 20, 2010.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MEDTRONIC, INC.
	By:	/s/ D. Cameron Findlay
		D. Cameron Findlay
		Senior Vice President, General
		Counsel and Corporate Secretary

Date: December 20, 2010

Exhibit Index

Exhibit Number		Description

Exhibit 99.1		Press Release of Medtronic, Inc., dated December 20, 2010.

EX-99.1 2 ex99.htm EXHIBIT 99.1 ex99.htm

Exhibit 99.1

	Contacts:
	Steve Cragle	Jeff Warren
	Public Relations	Investor Relations
	763-505-2345	763-505-2696

MEDTRONIC ANNOUNCES CHAIRMAN AND CEO WILLIAM A. HAWKINS TO RETIRE AT END OF COMPANY’S CURRENT FISCAL YEAR

MINNEAPOLIS – Dec. 20, 2010 – Medtronic (NYSE: MDT) announced today that William A. Hawkins intends to retire as Chairman and CEO of Medtronic at the conclusion of the current fiscal year ending April 29, 2011. The company’s board of directors has initiated an external search for his replacement, and Mr. Hawkins plans to remain until his successor is appointed.

“Bill has made a very significant impact at Medtronic and his service is deeply appreciated,” said Ken Powell, lead director on Medtronic’s Board of Directors and Chairman of the board’s Corporate Governance Committee. “We will be working closely with him in the coming months to ensure an orderly transition.”

”I am proud of what we have accomplished during my tenure at Medtronic and am confident that we made the right investments in talent, quality and innovation to position the company for long-term growth and future success,” said Hawkins. “It has been an honor and a privilege to lead such a talented, committed organization and I will work closely with the board to ensure that the transition to my successor is smooth and effective.”

Mr. Hawkins, 56, was elected CEO in August of 2007 and chairman of the board in 2008. He joined the company in 2002 as senior vice president and president of the company’s Vascular business and became president and chief operating officer in 2004.

About Medtronic

Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.

# # #